← Back to Search

Let's Discuss Health Website for Prostate Cancer

N/A

Recruiting

Led By Marie-Andrée Fortin, MD

Research Sponsored by Ciusss de L'Est de l'Île de Montréal

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at the end of the study, up to 1.5 years

Awards & highlights

Study Summary

This trial aims to improve communication between cancer patients and their caregivers, reduce psychological distress and help patients better understand their treatments to reduce health costs and improve outcomes. #cancer #communication #caregivers #patient

Who is the study for?

This trial is for French-speaking men comfortable with the internet, diagnosed with prostate cancer, and have access to a digital device. They should be able to give informed consent and not have any severe health issues or conditions like dementia that would impair their ability to participate.Check my eligibility

What is being tested?

The study tests the 'Let's Discuss Health' website designed to improve communication between patients with prostate cancer and their doctors, aiming to reduce psychological distress and increase treatment adherence.See study design

What are the potential side effects?

Since this intervention involves using a website for better communication rather than medication or medical procedures, there are no direct physical side effects expected from participating in this trial.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at the end of the study, up to 1.5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at the end of the study, up to 1.5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and at the end of the study, up to 1.5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Adherence to the care pathway

Dialogic rate in the exchanges during the initial patient-radiation oncologist encounter

Dialogic rate of the conversations during the end-of-treatment patient-radiation oncologist encounter

+4 more

Secondary outcome measures

Change in emotional distress following the medical encounter

Frequency of themes discussed during the end-of-treatment patient-radiation oncologist encounter

Frequency of themes discussed during the initial patient-radiation oncologist encounter

+9 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Let's Discuss Health GroupExperimental Treatment1 Intervention

Patients in this group will be encouraged to prepare each of the four medical encounters targeted in the trajectory in radiation oncology using Let's Discuss Health website, which are the initial visit, the mid-treatment visit, the end-of-treatment visit and the 3-month post-treatment visit.

Group II: Usual Care GroupActive Control1 Intervention

Patients in this group will received the usual care in the radiation oncology care pathway.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

CHU de Quebec-Universite LavalOTHER

167 Previous Clinical Trials

106,857 Total Patients Enrolled

Ciusss de L'Est de l'Île de MontréalLead Sponsor

70 Previous Clinical Trials

5,260 Total Patients Enrolled

Hopital Cité de la SantéUNKNOWN

Media Library

Let's Discuss Health Group Clinical Trial Eligibility Overview. Trial Name: NCT05787145 — N/A

Communication Research Study Groups: Let's Discuss Health Group, Usual Care Group

Communication Clinical Trial 2023: Let's Discuss Health Group Highlights & Side Effects. Trial Name: NCT05787145 — N/A

Let's Discuss Health Group 2023 Treatment Timeline for Medical Study. Trial Name: NCT05787145 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current enrollment of this experiment?

"Affirmative. The information on clinicaltrials.gov confirms that this medical trial is recruiting patients and was initially posted on 3rd October 2021. Its most recent update occurred 24th March 2023 and 300 individuals need to be enrolled from three different sites."

Answered by AI

Is this medical experiment currently enrolling participants?

"Data found on clinicaltrials.gov reveals that this medical trial is presently recruiting patients and has been since 3/10/2021, with the last update to the listing being made on 3/24/2023."

Answered by AI

What goals does this clinical trial aspire to accomplish?

"This clinical trial is estimated to run for up to 5 months and aims to measure the adherence of patients to their designated care pathway. Secondary outcomes include gauging patient appreciation of the Let’s Discuss Health website by employing a 4-point Likert scale, evaluating radiation oncologist perception regarding communication quality with ratings from 0-10, as well as determining frequency of themes discussed during initial meetings via Medicode's medical interview coding system."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

ComCancer: Use of Let's Discuss Health Website by Patients With Prostate Cancer Undergoing Radiation Oncology Treatment

2021. "ComCancer: Use of Let's Discuss Health Website by Patients With Prostate Cancer Undergoing Radiation Oncology Treatment". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05787145.

All > Prostate Cancer